Nycomed
New chief executive for Takeda
March 4, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actos, Millennium, Nycomed, Takeda, Yasuchika Hasegawa, christophe weber
Japanese pharma giant Takeda has added the title of chief executive to its representative director, president and chief operating officer …
Takeda opens Russian manufacturing facility
September 11, 2012Manufacturing and Production Actovegin, Nycomed, Russia, Takeda
Takeda Pharmaceutical has officially opened its new manufacturing facility in Yaroslavl, Russia, and expects it to be operating at full …
Takeda to cut 2,800 jobs
January 19, 2012Business Services, Research and Development, Sales and Marketing Nycomed, Takeda, job cuts
Takeda has announced plans to significantly reduce its global headcount over the next four years following its merger with Nycomed. …
NICE rejects Merck’s COPD drug Daxas
December 9, 2011Sales and Marketing COPD, Daxas, Merck, Nycomed
NICE has not recommended Merck’s COPD drug Daxas and is asking for a new clinical trial to test its effectiveness. …
Takeda completes Nycomed acquisition, installs new chief executive
October 3, 2011Sales and Marketing Nycomed, Takeda
Takeda Pharmaceutical Company has completed its acquisition of Nycomed and named Frank Morich as chief executive of the Zurich-based firm. …
Nycomed gains new European licence for cancer pain spray
July 4, 2011Sales and Marketing Nycomed, cancer pain, pain therapeutics
The European Commission has approved Nycomed’s Instanyl in a single-dose nasal spray for the treatment of breakthrough pain in cancer …
Takeda buys Nycomed for $13.6bn
May 19, 2011Manufacturing and Production, Research and Development, Sales and Marketing Nycomed, Takeda
Takeda has acquired Swiss specialist pharma firm Nycomed, boosting its presence in emerging markets. The deal comes in at 9.6 …
Takeda denies $12bn Nycomed takeover reports
May 13, 2011Research and Development, Sales and Marketing Nycomed, Takeda
Japan’s biggest pharma firm Takeda has denied reports it is negotiating a billion dollar deal to acquire Swiss speciality firm …
Nycomed files short bowel syndrome treatment
March 28, 2011Medical Communications Nycomed, Revestive, gastrointestinal
Specialist pharma company Nycomed has submitted a novel bowel disease treatment for assessment by European regulators. The Marketing Authorisation Application …
EU regulators launch fresh raids on pharma
December 7, 2010Sales and Marketing AstraZeneca, European Commission, Losec, Nexium, Nycomed, Pantazol, Ratiopharm, antitrust investigation, esomeprazole, pantoprazole
Competition regulators from the EU have raided offices of AstraZeneca and Nycomed in connection with alleged attempts to block generic …
Nycomed’s Q3 undermined by pantoprazole decline
November 11, 2010Sales and Marketing Daxas, Guangdong Techpool Bio-Pharma, Nycomed, Protium, pantoprazole
Nycomed has seen its sales inch downwards in the third quarter, as the decline of its biggest seller pantoprazole continued. …
Nycomed expands China presence with Techpool stake
November 2, 2010Research and Development, Sales and Marketing China, Guangdong Techpool biopharma, Nycomed, emerging markets, emerging pharma markets
Swiss-based Nycomed has acquired a majority stake in Guangdong Techpool biopharma in China, extending its presence in the top tier …
Digital Pharma: Pharma iPhone app update
October 15, 2010Medical Communications Astellas, Boehringer, Digital Pharma blog, GlaxoSmithKline, Lundbeck, Menarini, Nycomed, Pfizer, Servier, Teva, app, iphone
The ranks of pharma iPhone apps are increasing all the time and recent months have seen new additions from Teva, …
Zydus Nycomed’s API plant to start production soon
October 4, 2010Manufacturing and Production API, India, Nycomed, Zydus Cadila
Nycomed has said that construction and validation of an active pharmaceutical ingredient manufacturing unit at its plant in Navi Mumbai, …
GE Healthcare and Nycomed in Russian joint venture
April 27, 2010Sales and Marketing GE Healthcare, Nycomed
GE Healthcare and Nycomed have formed a joint venture to market and distribute GE Healthcare’s medical diagnostic contrast agents in …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
